Olaparib (Lynparza)
Olaparib (pronounced [oh LAP a rib]) is also known by the brand name, Lynparza. It is an antineoplastic (anticancer) drug that belongs to a class called PARP inhibitors, and it may be prescribed alone or in combination with other anticancer
Rituximab (Rituxan)
Rituximab (pronounced [ri TUK si mab]) is also known by the brand name, Rituxin. Rituximab is a type of chemotherapy, and it is an antineoplastic (anti-cancer) drug that belongs to a class called anti-CD20 monoclonal antibodies.
Pegfilgrastim (Fulphila)
Pegfilgrastim (pronounced [peg fil GRA stim]), which is also known by the brand name, Neulasta, is a hematopoietic agent that is used to treat neutropenia. Neulasta was the first medication produced based on the active element pegfilgrastim. Pegfilgrastim is not
Capecitabine (Xeloda)
Capecitabine (pronounced [ka pe SITE a been]) is also known by the brand name, Xeloda. Capecitabine is an antineoplastic (anticancer) drug that belongs to a class called antimetabolites (metabolic inhibitor), and it may be prescribed alone or in combination with
Lenvatinib (Lenvima)
Lenvatinib (pronounced [len VA ti nib]) is also known by the brand name, Lenvima. It is an antineoplastic (anti-cancer) drug that belongs to a class called tyrosine kinase inhibitors (TKI) of vascular endothelial growth factor (VEGF) receptors. TKIs work by
Cabozantinib (Cabometyx)
Cabozantinib (pronounced [ka boe ZAN ti nib]) is also known by the brand names, Cabometyx or Cometriq. This medication is a type of chemotherapy. Cabozantinib belongs to a class of drugs known as tyrosine kinase inhibitors (TKIs), which work
Filgrastim (Zarxio)
Filgrastim (pronounced [fil GRA stim]) is also known by the brand name Neupogen. Other available biosimilars include Zarxio, Granix, and Nivestym. Neupogen was the first medication produced based on the active element, filgrastim. These drugs have been used successfully for
Pegfilgrastim (Neulasta)
Pegfilgrastim (pronounced [peg fil GRA stim]), which is also known by the brand name, Neulasta, is a hematopoietic agent that is used to treat neutropenia. Neulasta was the first medication produced based on the active element pegfilgrastim. Pegfilgrastim is not
Hypogammaglobulinemia
Hypogammaglobulinemia is a disorder caused by low levels of serum immunoglobulins or antibodies. Immunoglobulins (IG) are the main components of immune response and can recognize antigens (foreign substances) to trigger an immune response and eliminate the infection. There are several